Thanks for breaking that down for us Cindy and for the explanation, it helps to understand the whole process.
i came across the drug application for Librera (freedom of information) and I’ll include the link here for anyone who wants to read it. Perhaps someone who has more knowledge of how these studies are conducted could read it and explain it to us lay people…in my opinion from what I’ve read of it I wouldn’t give this to my dog but I’m interested to hear what those who can understand these studies have to say.
Also, what I found interesting (and shocking) is that here in Canada they had the drug company update the product information sheet based on the number of adverse reactions reported (twice…once before it was approved and once after) but that in some provinces vets are not required to share that information with pet owners! THAT is why it’s so important to research these things yourself. You really can’t depend on your vet to give you the information needed to make an informed decision (especially when the drug companies go to the vet clinics to push this drug!
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/13959
rereading the article about the adverse reactions I wonder if you guys caught the part where Zoetis is now going to push vets to prescribe Librera for less severe forms of arthritis…
“And the company is encouraging vets to prescribe Librela more often, for moderate cases. This fall, the company’s “field force” is planning to visit vet clinics with that message”
We’ll soon see more adverse reactions if the number of dogs taking it increases.
Edward Bassingthwaighte, a veterinarian in Taradale, Australia, believes Librela should only be used as a last resort.
“There is no way in the world that I believe that Librela should ever be a first treatment for arthritis,” he said.
Dr. Bassingthwaighte has not prescribed the drug, citing concerns about the adverse reaction reports that pet owners around the world are sharing. He has also heard from other veterinarians who have observed animals’ physical mobility deteriorating after taking the drug.
“You get quite a large number of animals that will be okay with it, but you’ve got obviously a pretty heavy, sensitive tail of the bell curve that are not coping with it,” said Dr. Bassingthwaighte. “…I basically want people to understand that these drugs are not without risk. And I think the risk is being minimized.”